| abstract |
SUMMARY The present invention relates to innovative methods for pre-enhancing the therapeutic effects of cancer prior to treatment with chemotherapy, radiotherapy or immunotherapy, and the novel cytokine mixture used in the method. A cytokine mixture is a serum-free mitogen that contains a specific ratio of cytokines to interleukin 2 (IL-2), eg cytokines such as IL-1β, TNF-α, IFN-γ and GM-CSF. A mixture that is effective to induce cancer cells to enter the proliferative cell division cycle phase and increase the vulnerability of the cancer cells to chemotherapy, radiation therapy and immunotherapy. One such novel cytokine mixture is Multikine (TM), which can be used alone or in combination with other drugs for cancer treatment, thus the success rate of cancer treatment and cancer The disease-free survival rate of patients can be increased. |